U.K.-based AiOne Healthcare Technologies Ltd. announced that it has entered a strategic partnership with DeepTek.ai to bring DeepTek's medical AI image management and processing capabilities to the U.K. market.
In its announcement, AiOne noted DeepTek's Augmento platform. Earlier this year, Augmento received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the class II device intended to be used as a platform for the diagnosis and analysis of radiology images by trained and qualified medical personnel, such as radiologists, physicians, nurses, and medical technicians. It provides optional integration with FDA-cleared third-party AI models, according to information available at the FDA.
AiOne said it will provide DeepTek.ai with market access in the U.K., support, and integration expertise.
